Diabetic Neuropathic Pain
Neurology
Prevalence
3200.0 / 100K
Incidence
300.0 / 100K/yr
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| prtt-200 | PROTECT PHARMACEUTICAL CORP (PRTT) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| ath-1020 | LeonaBio, Inc. (LONA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Diabetic Neuropathic Pain?
BioSniper tracks 2 drugs in development for Diabetic Neuropathic Pain across 2 companies.
How many clinical trials target Diabetic Neuropathic Pain?
There are 1 clinical trial targeting Diabetic Neuropathic Pain tracked by BioSniper.
What is the prevalence of Diabetic Neuropathic Pain?
The estimated prevalence of Diabetic Neuropathic Pain is approximately 3200.0 per 100,000 population.
Deep-dive into Diabetic Neuropathic Pain
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis